BsAbs such as bintrafusp alfa (M7824), YM101, and BiTP are designed to simultaneously block PD‐L1 signaling and neutralize TGF‐β activity, thereby restoring anti‐tumor immunity. This evidence concerns the gene TGFB1 and neoplasm.